Speaker Profile
MBA, CEO, EveryONE Medicines
Biography
Kent Rogers has been a senior executive across the healthcare industry for over 30 years, focusing on product commercialization, supply chain logistics, pricing strategies, reimbursement, market access, and alliance management. He spent more than two decades in the pharmaceutical industry in multiple leadership and executive roles at several top-tier pharmaceutical firms as well as biotech startups. Kent also worked on the payer side of the industry at OptumRx, a national PBM for United Health Group. Today, Kent is with EveryONE Medicines, a biotech startup focused on developing medications to treat n-of-1, neurodegenerative diseases. He sits on several boards and currently serves as a Partner with ARCH Venture Partners.
Talk
Treating The Rarest Diseases At Scale
There is no regulatory pathway for approving medicines to treat so-called n-of-1 diseases. New guidance has been issued in the US and there is movement in that direction in the EU. A scalable and sustainable solution is possible now.
Emerging Therapeutics Showcase:
EveryONE Medicines
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
